View by Specialty

Trending

PC0924Houry_Graphic_01_WEB
September 11, 2024
4 min read
Save

CDC data reveal three social drivers that influence suicide risk

Gastroenterology News

SPONSORED CONTENT
Save
SPONSORED CONTENT
August 07, 2024
4 min read
Save

Q&A: Illicit fentanyl use raises hepatitis C risk among injection drug users

Q&A: Illicit fentanyl use raises hepatitis C risk among injection drug users

A new study provides the first evidence that illicit fentanyl use may play a role in hepatitis C transmission among injection drug users, according to researchers.

SPONSORED CONTENT
August 05, 2024
11 min watch
Save

VIDEO: Healio Gastroenterology announces nominees for 2024 Disruptive Innovators Awards

VIDEO: Healio Gastroenterology announces nominees for 2024 Disruptive Innovators Awards

Healio Gastroenterology is excited to announce the nominees for its annual Disruptive Innovators Awards in gastroenterology and hepatology.

Trending

PC0924Houry_Graphic_01_WEB
September 11, 2024
4 min read
Save

CDC data reveal three social drivers that influence suicide risk

SPONSORED CONTENT
August 02, 2024
2 min read
Save

‘Gold standard evidence’ supports use of probiotic blend to improve constipation

‘Gold standard evidence’ supports use of probiotic blend to improve constipation

CHICAGO — Adults with occasional constipation reported significant improvement in stool consistency and GI-related symptoms after receiving a probiotic blend, results from a randomized study presented at NUTRITION showed.

SPONSORED CONTENT
July 29, 2024
2 min read
Save

‘Tremendous leap forward’: FDA approves first colorectal cancer blood test

‘Tremendous leap forward’: FDA approves first colorectal cancer blood test

The FDA has approved Guardant Health’s Shield blood test to screen for colorectal cancer in patients aged 45 years and older at average risk for disease, according to a company press release.

SPONSORED CONTENT
July 26, 2024
4 min read
Save

‘It’s time for action’: World Hepatitis Day calls to end an ‘entirely preventable disease’

‘It’s time for action’: World Hepatitis Day calls to end an ‘entirely preventable disease’

Every year on July 28th, clinicians and researchers recognize World Hepatitis Day to bring awareness to one of the world’s deadliest but preventable viruses and continue efforts to meet the global goal of eliminating viral hepatitis by 2030

SPONSORED CONTENT
July 22, 2024
3 min read
Save

Q&A: Stool samples could help diagnose autism early, researchers say

Q&A: Stool samples could help diagnose autism early, researchers say

Findings from a study that identified differences in the gut microbiota of children with autism indicate that stool sample testing could be used as an early, noninvasive diagnostic tool for autism, researchers reported.

SPONSORED CONTENT
July 17, 2024
2 min read
Save

Q&A: Risk for long COVID has declined, remains ‘substantial’

Q&A: Risk for long COVID has declined, remains ‘substantial’

The risk for developing long COVID declined over the course of the pandemic but has remained significant, researchers reported.

SPONSORED CONTENT
July 17, 2024
2 min read
Save

Mayo Clinic ranks No. 1 in US for gastroenterology, GI surgery for 9th consecutive year

Mayo Clinic ranks No. 1 in US for gastroenterology, GI surgery for 9th consecutive year

For the ninth consecutive year, the Mayo Clinic has been named the best hospital in the United States for gastroenterology and gastrointestinal surgery, according to the 2024-2025 U.S. News & World Report Best Hospitals rankings.

SPONSORED CONTENT
July 10, 2024
2 min read
Save

To initiate same-day hepatitis C testing and treatment, hepatitis B status must be known

To initiate same-day hepatitis C testing and treatment, hepatitis B status must be known

The FDA’s recent authorization of a rapid, point-of-care test to diagnose current hepatitis C virus infection is a major victory, but it would be malpractice to initiate same-day HCV treatment if a patient’s hepatitis B virus status is unknown.

SPONSORED CONTENT
July 09, 2024
3 min read
Save

Q&A: Phenotype test predicting semaglutide response could ‘change conversation’ on obesity

Q&A: Phenotype test predicting semaglutide response could ‘change conversation’ on obesity

In a Healio exclusive, Andres J. Acosta, MD, PhD, highlights data demonstrating that the MyPhenome test may serve as a biomarker to determine whether a patient with obesity will be a “good responder” to semaglutide.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails